PharmaVault
گنجینه اطلاعات داروسازی
The Pharmaceutical Information Vault
Excipient monograph · مونوگراف ماده جانبی
pharmavault.ir
Histidine
هیستیدین
1Nonproprietary names
- JPL-Histidine
- Ph. Eur.Histidine
- BPHistidine
- USP–NFHistidine
2Synonyms and trade names
L-histidine; His; (S)-2-amino-3-(imidazol-4-yl)propanoic acid; α-amino-β-imidazolepropionic acid
3Chemical name and CAS Registry Number
(S)-2-Amino-3-(1H-imidazol-4-yl)propanoic acid · [71-00-1]
UNII 4QD397987E · PubChem CID 6274
4Empirical formula and molecular weight
C6H9N3O2 · 155.15
5Functional category
pH adjuster, buffering agent
Typical concentrations: — · Dosage forms: Sterile (parenteral/ophthalmic)
6Applications in pharmaceutical formulation
Widely used as a buffer in biopharmaceutical formulations, particularly monoclonal antibodies for subcutaneous and intravenous use, typically at about 10–20 mM and pH 5.5–6.5 where the imidazole group buffers. It also acts as a stabiliser that reduces protein aggregation, as a cryo- and lyoprotectant in freeze-dried products, and as a nutrient in parenteral nutrition solutions.
7Description
White crystals or crystalline powder, odourless and with a slightly bitter taste. It is an essential amino acid; the pharmacopoeial material is the L-enantiomer.
8Typical properties
- pKa
- ≈ 1.8 (carboxyl), ≈ 6.0 (imidazole) and ≈ 9.2 (amino)
- Isoelectric point
- ≈ 7.6
- Melting point
- decomposes at about 280 °C
- Solubility
- soluble in water (about 4 g/100 mL at 25 °C); very slightly soluble in ethanol
- Buffer range
- about pH 5.0–7.0
9Stability and storage conditions
Stable as a solid; store in a well-closed container protected from light. In solution, histidine is susceptible to metal-catalysed and light-induced oxidation, and its degradation products can promote oxidation or discoloration of proteins. Solutions are usually prepared fresh or protected from light.
10Incompatibilities
Chelates transition-metal ions such as copper, zinc and iron. Incompatible with strong oxidising agents; as an amine it can undergo Maillard reaction with reducing sugars.
11Method of manufacture
Produced mainly by microbial fermentation, followed by isolation and purification by ion-exchange and crystallisation.
12Safety
An essential dietary amino acid, regarded as non-toxic and non-irritant at the concentrations used as a buffer.
13Handling precautions
Observe normal precautions for the quantity handled; eye protection and gloves are recommended.
14Regulatory status
Included in the FDA Inactive Ingredient Database (intravenous and subcutaneous injections) and in parenteral medicines licensed in Europe, including many biological products.
15Related substances
Histidine hydrochloride monohydrate; arginine; glycine; methionine.
16Comments
Histidine buffers are normally prepared from a combination of L-histidine and L-histidine hydrochloride monohydrate to reach the target pH without strong acids. The buffer pH of histidine changes noticeably with temperature, which should be considered for products stored refrigerated or frozen.